About us

Our commitment is to revolutionize aging assessment, providing insights that empower proactive health management.

At NovaAging, we are dedicated to advancing healthcare by integrating cutting-edge epigenetic science into clinical practice. Our mission is to equip healthcare professionals with precise, actionable insights into biological aging, enabling personalized interventions that promote optimal health outcomes.

Request a Demo

Our vision

Science-Driven Approach

We prioritize rigorous scientific methodologies, ensuring that our services are grounded in validated research and contribute meaningfully to the field of longevity science.

Accessible Personalized Healthcare

By translating complex epigenetic data into clear, actionable recommendations, we empower healthcare professionals to tailor interventions that measurably improve patient outcomes.

Global Collaboration

Our global network of experts and advisors fosters a collaborative environment that accelerates innovation and expands the reach and impact of our work.

Meet our advisors

Dr. Ricardo di Lazzaro Filho photo

Dr. Ricardo di Lazzaro Filho

With an MD and PharmD from the University of São Paulo (USP), Dr. di Lazzaro is a prominent healthtech entrepreneur and startup investor. He co-founded Genera, the largest personal genomics laboratory in Latin America, and was recognized by MIT Technology Review as one of the Innovators Under 35 Latam. He holds a Master's degree in Genetic Counseling and Human Genomics and is pursuing a PhD in Genetics and Evolutionary Biology at USP.
Lucas Paulo de Lima Camillo photo

Lucas Paulo de Lima Camillo

Lucas is a biochemist and researcher specializing in aging, epigenetics, and machine learning. He earned a B.Sc. in Biochemistry and Molecular Biology from Brown University, and pursued further studies in Computer Science and Biochemistry at the University of Oxford. Currently, he is completing a Bachelor of Arts in Medicine at the University of Cambridge. Lucas is Head of Machine Learning at Shift Bioscience and a Tech Fellow at Fundação Estudar. His research on advanced epigenetic biomarkers has been published in leading scientific journals.

For more information about our methodologies, technologies, or the potential of epigenetics in healthcare, please contact us. We are excited to collaborate in shaping the future of personalized medicine.